Pharmaceuticals · Projected milestone
AI-found antibiotic classes
Estimated year~2032
20% by 2037 · including earlier years
The year is an editorial timing estimate. The percentage applies to occurrence by the stated deadline. These estimates are not calibrated odds.
Antibiotics discovered by AI are approved against resistant bacteria.
Explore this milestone on the interactive mapWhat the forecast means
Milestone stage: milestone (legacy definition)
Completion criteria: Legacy milestone: refine the observable threshold before resolving.
This page describes a forecast, rather than an achieved result. Read the methodology and assumptions.
Built on
- StreptomycinRecorded · 1943enables
- AI accelerator chipsRecorded · 2016requires
- AI finds a new antibioticRecorded · 2020enables
- Computationally designed drug reaches FDA reviewRecorded · 2026enables
- Zasocitinib wins FDA approvalForecast · ~2027influences
- Clinically validated phage-matching platformForecast · ~2033influences
Led to
Sources & evidence
No individual source links are recorded for this milestone. Source coverage and review status vary across the atlas.
Dataset updated 2026-10-18. This individual record has not been separately re-reviewed.